Ronald Blue Trust Inc. boosted its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 16.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,805 shares of the healthcare product maker’s stock after purchasing an additional 3,125 […]
SlateStone Wealth LLC grew its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 209.7% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 41,733 shares of the healthcare product maker’s stock after purchasing an additional 28,259 shares during […]
Sageworth Trust Co cut its holdings in Vanguard Total Stock Market ETF (NYSEARCA:VTI – Free Report) by 0.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,104,349 shares of the company’s stock after selling 6,850 shares during the period. Vanguard Total […]
McLean Asset Management Corp grew its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 7.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,217 shares of the healthcare product maker’s stock after acquiring an additional 146 […]
CFM Wealth Partners LLC trimmed its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 22.8% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 8,268 shares of the healthcare product maker’s stock after selling 2,447 shares during the period. CFM Wealth Partners LLC’s holdings in Abbott Laboratories […]